Skip to main content
NCBI home page
Atencion Primaria logoLink to Atencion Primaria
. 2013 Apr 5;30(6):392–400. [Article in Spanish] doi: 10.1016/S0212-6567(02)79053-7

Bioterrorismo y atención primaria

Grupo de Prevención en Enfermedades Infecciosas (PAPPS-semFYC); Grupo de Enfermedades Infecciosas (semFYC)*,**
PMCID: PMC7677922  PMID: 12396947

The content is available as a PDF (336.5 KB).

Bibliografía

  • 1.Siegrist DW. The threat of biological attack: why concern now? Emerging infectious diseases [consultado 06/02]. Disponible en: http://www.cdc.gov/ncidod/EID/vol5no4/siegrist.htm [DOI] [PMC free article] [PubMed]
  • 2.Korteper M.G., Parker G.W. Potential biological weapons threats. Emerg Infect Dis. 1999;5:523–527. doi: 10.3201/eid0504.990411. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.CDC Biological and chemical terrorism: strategic plan for 3 preparedness and response. MMWR. 2000;49:1–14. [PubMed] [Google Scholar]
  • 4.Recognition of illness associated with the intencional release of a biologic agent. MMWR. 2001;50:893–897. [PubMed] [Google Scholar]
  • 5.CDC Bioterrorism alleging use of ántrax and Interin Guidelines for Management. 1999;48:69–74. [PubMed] [Google Scholar]
  • 6.Franz D., Jahrling P., Friedlander A. Clinical recognition and management of patients exposed to biological warfare agents. JAMA. 1997;278:399–411. doi: 10.1001/jama.278.5.399. [DOI] [PubMed] [Google Scholar]
  • 7.Recommendations of the A.C.I.P. Use of anthrax vaccine in the United States. MMWR. 2000;49:1–20. [PubMed] [Google Scholar]
  • 8.Pile J., Malone J.P., Eitzen E.N., Friedlander A. Anthrax as a potencial biological warfare agent. Arch Intern Med. 1998;158:429–434. doi: 10.1001/archinte.158.5.429. [DOI] [PubMed] [Google Scholar]
  • 9.Dirección General de Salud Pública. Enfermedades de Declaración Obligatoria. Valencia: Generalitat de Valencia. Conselleria de Sanitat [consultado 07/02]. Disponible en: dgsp.san.gva.es/SSCC/Epidemiologia/edo/EDOs/series/carbunco.htm
  • 10.Christopher G.W., Ciestack T.J., Pavlin J.A., Eitzen E.M. Biological warfare: a histotical perspective. JAMA. 1997;278:412–417. [PubMed] [Google Scholar]
  • 11.Zilinskas R.A. Iraq’s biological weapons: the past as future? JAMA. 1997;278:418–424. [PubMed] [Google Scholar]
  • 12.Inglesby T., Henderson D., Bartlett J., Ascher M., Eitzen E. Anthrax as a biological weapon. Medical and Public management. JAMA. 1999;281:1735–1745. doi: 10.1001/jama.281.18.1735. [DOI] [PubMed] [Google Scholar]
  • 13.McGovern T., George C., Eitzen E. Cutaneus manifestations of biological warfare and related threat agents. Arch Dermatol. 1999;135:311–322. doi: 10.1001/archderm.135.3.311. [DOI] [PubMed] [Google Scholar]
  • 14.Shafazand S., Doyle R., Ruoss S., Weinacker A., Raffin T.A. Inhalation anthrax: epidemiology, diagnosis and management. Chest. 1999;116:1369–1376. doi: 10.1378/chest.116.5.1369. [DOI] [PubMed] [Google Scholar]
  • 15.Gestal J., Cortina P., Delgado M. Vacunas de aplicación no sistemática de uso poco frecuente. In: Salleras L.l., editor. Vacunaciones preventivas. Masson; Principios y aplicaciones. Barcelona: 1998. [Google Scholar]
  • 16.CDC Health Advisory. How to handle anthrax and other biological agent threats [consultado 06/02]. Disponible en: http://www.bt.cdc.gov/DocumentsApp/Anthrax/10122001Handle/10122001Handle.asp
  • 17.Nass M. New vaccines and new vaccine technology. Infect Dis Clin North Am 1999;13:187-208 [consultado 06/02]. Disponible en: http://www.anthraxvaccine.org/AVmodel.htm [DOI] [PubMed]
  • 18.Friedlander A., Pittman Ph., Parker G. Anthrax vaccine: evidence for safety and efficacy against inhalational anthrax. JAMA. 1999;282:2104–2106. doi: 10.1001/jama.282.22.2104. [DOI] [PubMed] [Google Scholar]
  • 19.Henderson D.A., Inglesby T., Bartlett J., Ascher M., Eitzen E. Smallpox as biological Weapon. JAMA. 1999;281:2127–2137. doi: 10.1001/jama.281.22.2127. [DOI] [PubMed] [Google Scholar]
  • 20.Vaccinia (Smallpox) Vaccine Recommendations of the Advisory Committee on Immunnization Practices (ACIP) MMWR Recommendations and Reports. 2001;50:1–25. [PubMed] [Google Scholar]
  • 21.Rosenthal S., Merchlinsky M., Kleppinger C., Goldenthal K. Developing new smallpox vaccines. Emerg Infect Dis. 2001;7:920–926. doi: 10.3201/eid0706.010602. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.LeDuc J., Jahrling P. Strengthening national preparedness for smallpox: an update. Emerg Infect Dis. 2001;7:155–157. doi: 10.3201/eid0701.700155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Meltzer M, Damon I, LeDuc, Donald M. Modeling potencial responses to smallpox as a bioterrorist weapon. Emerg Infect Dis [consultado 06/02]. Disponible en: http://www.cdc.gov/ncidod/EID/vol7no6/meltzer.htm [DOI] [PMC free article] [PubMed]
  • 24.Inglesby T.V., Dennis D., Henderson D., Bartlett J., Ascher M. Plague as biological weapon. JAMA. 2000;283:2281–2890. doi: 10.1001/jama.283.17.2281. [DOI] [PubMed] [Google Scholar]
  • 25.Arnon S., Schechter R., Inglesby T., Henderson D., Bartlett J. Botulinum toxin as biological weapon. JAMA. 2001;285:1059–1067. doi: 10.1001/jama.285.8.1059. [DOI] [PubMed] [Google Scholar]
  • 26.Wound Botulism in California, 1995 MMWR. 1995;44:889–892. [PubMed] [Google Scholar]
  • 27.Anónimo Psycological implications of chemical and biological weapons. BMJ. 2001;323:878–879. doi: 10.1136/bmj.323.7318.878. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Anónimo Appropiate responses to bioterrorist threats. BMJ. 2001;323:877–878. doi: 10.1136/bmj.323.7318.877. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Clarke R.A. Finding the right balance against bioterrorism. Emerg Infect Dis [consultado 06/02]. Disponible en: http://www.cdc.gov/ncidod/EID/vol5no4/clarke.htm [DOI] [PMC free article] [PubMed]
  • 30.Cardeñosa N., Domínguez A., Monterde R., Pascual A., Salleras L. Respuesta sanitaria ante un ataque terrorista con agentes causales de enfermedades inmunoprevenibles. Vacunas. 2002;1:34–39. [Google Scholar]
  • 31.Gourlay M, Siwek J. Resources in the war against bioterrorism. American Family Phisycian [consultado en 06/02]. Disponible en: http://www.aafp.org/afp/20011115/editorials.html [PubMed]

Articles from Atencion Primaria are provided here courtesy of Elsevier

RESOURCES